- Home
- VNDA vs TTRX Comparison
VNDA vs TTRX Comparison
Compare VNDA & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- TTRX
- Stock Information
- Founded
- VNDA 2002
- TTRX 2015
- Country
- VNDA United States
- TTRX United States
- Employees
- VNDA N/A
- TTRX N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- TTRX Biotechnology: Pharmaceutical Preparations
- Sector
- VNDA Health Care
- TTRX Health Care
- Exchange
- VNDA Nasdaq
- TTRX Nasdaq
- Market Cap
- VNDA 289.0M
- TTRX 257.8M
- IPO Year
- VNDA 2006
- TTRX N/A
- Fundamental
- Price
- VNDA $5.28
- TTRX $3.43
- Analyst Decision
- VNDA Strong Buy
- TTRX
- Analyst Count
- VNDA 3
- TTRX 0
- Target Price
- VNDA $14.00
- TTRX N/A
- AVG Volume (30 Days)
- VNDA 993.5K
- TTRX 105.2K
- Earning Date
- VNDA 10-29-2025
- TTRX 01-01-0001
- Dividend Yield
- VNDA N/A
- TTRX N/A
- EPS Growth
- VNDA N/A
- TTRX N/A
- EPS
- VNDA N/A
- TTRX N/A
- Revenue
- VNDA $212,074,000.00
- TTRX N/A
- Revenue This Year
- VNDA $14.32
- TTRX N/A
- Revenue Next Year
- VNDA $37.05
- TTRX N/A
- P/E Ratio
- VNDA N/A
- TTRX N/A
- Revenue Growth
- VNDA 11.12
- TTRX N/A
- 52 Week Low
- VNDA $3.81
- TTRX $2.57
- 52 Week High
- VNDA $5.70
- TTRX $26.50
- Technical
- Relative Strength Index (RSI)
- VNDA 60.60
- TTRX N/A
- Support Level
- VNDA $4.72
- TTRX N/A
- Resistance Level
- VNDA $5.46
- TTRX N/A
- Average True Range (ATR)
- VNDA 0.24
- TTRX 0.00
- MACD
- VNDA 0.09
- TTRX 0.00
- Stochastic Oscillator
- VNDA 86.13
- TTRX 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.